Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National

Pharmaceutical giant to invest £300m in Britain after UK-US deal

  • Pharmaceutical giant AstraZeneca is set to invest £300 million into UK drug development, a commitment announced by Sir Keir Starmer.
  • This investment follows a US-UK agreement, finalised in April, aimed at increasing medicine prices in Britain.
  • The new funding marks a change in direction after AstraZeneca previously paused a £200 million expansion in Cambridge and scrapped plans for a £450 million vaccine plant in Merseyside.
  • Sir Keir Starmer hailed the investment as “significant”, stating it would “futureproof thousands of jobs” in Macclesfield and Cambridge.
  • The funds will be used to complete the Rosalind Franklin building on AstraZeneca's Cambridge campus and to develop a 'lab of the future' in Macclesfield, utilising digital and data tools for drug development.

IN FULL

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.